Parylene C is biocompatible and meets USP Class VI and ISO 10993 standards — the two primary benchmarks for medical device materials. It is the most widely deployed variant in the Parylene family for medical and implantable device applications. Its chlorinated para-xylylene structure delivers superior moisture barrier performance and chemical resistance while maintaining full biocompatibility with human tissue and fluids. Engineers evaluating Parylene C should weigh its exceptional protective properties against its mechanical limitations relative to bulk structural materials.
Parylene C is widely considered one of the most biocompatible conformal coatings used in medical devices. It forms a chemically inert, pinhole-free barrier that protects both the device and the human body from harmful interactions.
Because of its stability, low permeability, and proven safety profile, Parylene C is commonly used in implants, surgical tools, and wearable medical electronics.
Biocompatibility refers to a material's ability to perform safely in contact with the human body without causing adverse reactions such as toxicity, inflammation, or immune response.
Parylene C achieves this by acting as a non-reactive, protective barrier between device materials and biological environments. It prevents leaching, corrosion, and chemical interaction — key risks in medical applications.
Parylene C satisfies both primary biocompatibility standards used by medical device manufacturers and regulatory bodies:
Independent testing confirms Parylene C passes both standards. Its chemical inertness — meaning it does not react with bodily fluids, enzymes, or varying pH environments — is the primary reason for its compliance.
Parylene C's ability to create a continuous, defect-free film is critical. Unlike liquid coatings, it forms a uniform layer even on complex geometries, reducing exposure risks.
Parylene C has extremely low permeability to moisture and gases, which helps prevent corrosion and contamination in harsh biological environments.
It resists a wide range of chemicals, ensuring long-term stability when exposed to bodily fluids, enzymes, and varying pH levels.
Parylene C has a dielectric strength of up to 7,000 V/mil, making it ideal for implantable electronics and sensors that must function reliably in the body.
The chemical vapor deposition (CVD) process allows Parylene to coat intricate surfaces evenly at thicknesses as low as 1 micron, eliminating gaps that could compromise safety or device performance.
| Property | Parylene C | Silicone | Epoxy | Teflon (PTFE) |
|---|---|---|---|---|
| Biocompatibility Standard | USP Class VI, ISO 10993 | ISO 10993 | Moderate | ISO 10993 |
| Moisture Barrier | Excellent | Moderate | Good | Good |
| Conformality | Complete coverage | Limited | Limited | No |
| Thickness Control | Precise (micron-level) | Variable | Variable | 12–25 µm |
| PFAS-Free | Yes | Yes | Yes | No |
| Dielectric Strength | Up to 7,000 V/mil | ~500 V/mil | ~400 V/mil | ~2,000 V/mil |
This combination of properties is why Parylene C is often selected for critical medical and implantable applications — particularly where Teflon alternatives are needed due to tightening PFAS regulations.
The global Parylene market was valued at $98.38 million in 2023 and is projected to grow to $118.52 million by 2030, driven in large part by expanded medical device applications.
Yes. Parylene C enhances safety in two critical ways:
While Parylene C is highly biocompatible, it is not universally ideal for every application:
These challenges are typically addressed through proper engineering and process optimization — and in most cases, Parylene's performance advantages justify the added process complexity.
Yes. Parylene C meets USP Class VI and ISO 10993 biocompatibility standards — the primary requirements for implantable and body-contact medical devices. It is non-toxic, physiologically non-reactive, and has a decades-long track record in implantable applications, including pacemakers, stents, and cochlear implants.
Parylene itself is not an FDA-approved material — the FDA approves devices, not coating materials in isolation. However, Parylene C is widely used in devices that have received FDA clearance or approval, and its USP Class VI and ISO 10993 compliance makes it well-suited for inclusion in FDA submissions.
Yes. Its low permeability, pinhole-free structure, and chemical inertness make Parylene C highly effective at preventing corrosion caused by moisture, bodily fluids, and enzymatic activity.
Yes. Parylene C contains no per- or polyfluoroalkyl substances (PFAS) and is both REACH and RoHS compliant — unlike Teflon (PTFE), which is classified as a PFAS material. This makes Parylene a strong alternative for manufacturers navigating tightening PFAS regulations.
Parylene offers better moisture resistance, more precise thickness control, and more uniform coverage — especially on complex geometries. Silicone coatings are applied at significantly greater thickness and cannot achieve the pinhole-free conformality Parylene delivers via CVD.
Parylene is deposited via chemical vapor deposition (CVD) — a room-temperature process that conformally coats all exposed surfaces regardless of geometry. The process leaves no liquid residue and requires no curing step.
Read about how to incorporate Parylene into your process
If you're evaluating Parylene for medical or high-reliability applications, understanding its advantages and limitations is critical.
Explore more about Parylene coating properties or learn how it compares to other materials in our Parylene vs. liquid coatings guide.
Learn more in our webinar, Parylene: Pros, Cons, and Practicalities